Curtis Scribner

Dr. Scribner is a board-certified internist with 25+ years experience in drug development as a clinical investigator, regulatory reviewer, and product life cycle consultant, including senior positions at the CDC and FDA Center for Biologic Evaluation and Research. He has served as a consultant to biotechnology companies working on everything from discovery and preclinical models through clinical trials, Data Safety Monitoring Committees and regulatory interactions in the US and Europe, including as Chief Regulatory Officer of Intarcia and in medical and regulatory positions at several BridgeBio companies.